StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Non-GAAP adjusted net earnings by Year

Non-GAAP adjusted net earnings ($M) ($M)

Johnson & Johnson Non-GAAP adjusted net earnings: $26,215M in FY2025, up 8.1% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
26,215
Period ended Dec 28, 2025
Change on a year earlier
+8.1%
24,242 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| Net earnings | $ | 26,215 | 27.8 | $ | 24,242 | 27.3 | 8.1”

Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗

Reported in Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings & Non-GAAP Reconciliation.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up non-GAAP adjusted net earnings

Cite this data

StockData. (2026). Johnson & Johnson Non-GAAP adjusted net earnings ($M), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj-net-earnings

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.